AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16123205 — intervention group
Group type: EXPERIMENTAL
Intervention: Extravehicular activity (EVA) with denitrogenation procedures; initial cabin pressure 748 mmHg, final suit pressure approximately 295 or approximately 220 mmHg; no specific dosage or duration mentioned.
Number of subjects: 8
Study 16123205 — intervention group
Group type: COMPARATOR
Intervention: Measurements made in microgravity on days well separated from the EVA; control group not explicitly mentioned.
Number of subjects: 8
Study 12351939 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (beer, 40 g/day for men, 30 g/day for women)
Number of subjects: 19
Study 12351939 — intervention group
Group type: COMPARATOR
Intervention: No alcohol consumption (control)
Number of subjects: 19
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic 7219D
Number of subjects: 22
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic 7219C
Number of subjects: 22
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic 7223
Number of subjects: 22
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: CPI Ventak MINI
Number of subjects: 22
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: RV + IPP
Number of subjects: 22
Study 9990601 — intervention group
Group type: EXPERIMENTAL
Intervention: RV
Number of subjects: 22
Study 7560544 — intervention group
Group type: EXPERIMENTAL
Intervention: Org 3770
Number of subjects: 90
Study 7560544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 1580171 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose polymer beverage
Number of subjects: 76
Study 1580171 — intervention group
Group type: COMPARATOR
Intervention: Glucose monomer beverage
Number of subjects: 76
Study 1580171 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary test
Number of subjects: 76
Study 3894256 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone administered at 10h00
Number of subjects: 16
Study 3894256 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone administered at 22h00
Number of subjects: 16
Study 3894256 — intervention group
Group type: COMPARATOR
Intervention: Placebo period
Number of subjects: 16
Study 31136662 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt (220 g/d for 24 weeks)
Number of subjects: 100
Study 31136662 — intervention group
Group type: COMPARATOR
Intervention: Milk (control group, 220 g/d for 24 weeks)
Number of subjects: 100
Study 29140897 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow, sedative music
Number of subjects: 42
Study 29140897 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast, stimulative music
Number of subjects: 42
Study 29140897 — intervention group
Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 42
Study 26352702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral pain management program (4 weeks)
Number of subjects: 46
Study 26352702 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 46
Study 23957897 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing (BMI) intervention delivered by dental practitioners
Number of subjects: 60
Study 23957897 — intervention group
Group type: COMPARATOR
Intervention: Didactic control intervention
Number of subjects: 60
Study 22794220 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC placement immediately after MTA placement
Number of subjects: 50
Study 22794220 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC placement after 1 day of temporization
Number of subjects: 50
Study 22794220 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC placement after 7 days of temporization
Number of subjects: 50
Study 22794220 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC placement with a wet cotton pellet
Number of subjects: 50
Study 22794220 — intervention group
Group type: EXPERIMENTAL
Intervention: GIC placement without a wet cotton pellet
Number of subjects: 50
Study 20125104 — intervention group
Group type: EXPERIMENTAL
Intervention: LFHCCn-3 diet
Number of subjects: 29
Study 20125104 — intervention group
Group type: COMPARATOR
Intervention: HSFA diet
Number of subjects: 29
Study 18410686 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (8 treatment sessions, once a week, at individually selected points)
Number of subjects: 0
Study 18410686 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupuncture (8 sessions, one per week, at non-acupuncture points using minimal puncture technique)
Number of subjects: 0
Study 18410686 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (normal care)
Number of subjects: 0
Study 18410686 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum or sham acupuncture (subsample for brain perfusion study)
Number of subjects: 0
Study 15742431 — intervention group
Group type: EXPERIMENTAL
Intervention: LY333013 (50, 250, and 1000 mg)
Number of subjects: 251
Study 15742431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate-buffered, single-chamber bag PDF (Lac-PDF)
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered, double-chamber bag PDF (Bic-PDF)
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered, double-chamber bag PDF (Bic Hi-PDF)
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Lac-PDF
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Bic-PDF
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Bic Hi-PDF
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Lac-PDF
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Bic-PDF
Number of subjects: 8
Study 12556067 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Bic Hi-PDF
Number of subjects: 8
Study 9622469 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 28
Study 9622469 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment control
Number of subjects: 28
Study 7937271 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 25 mg
Number of subjects: 200
Study 7937271 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 50 mg
Number of subjects: 200
Study 7937271 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 100 mg
Number of subjects: 200
Study 7937271 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 200 mg
Number of subjects: 200
Study 7937271 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 200
Study 7937271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted patients
Number of subjects: 200
Study 7937271 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed patients
Number of subjects: 200
Study 3276271 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (various drugs or drug combinations)
Number of subjects: 547
Study 3276271 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics effective against oral microflora, especially anaerobic bacteria
Number of subjects: 547
Study 3276271 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics against gram-negative aerobic bacteria
Number of subjects: 547
Study 3276271 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative antibiotic administration
Number of subjects: 547
Study 3276271 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged administration of antibiotics
Number of subjects: 547
Study 28967980 — intervention group
Group type: EXPERIMENTAL
Intervention: Advancing Adolescents (8-week psychosocial intervention)
Number of subjects: 817
Study 28967980 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 817
Study 27855101 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 387
Study 27855101 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 387
Study 25163749 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 19
Study 25163749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 23099796 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with risedronate (35 mg weekly) and teriparatide (20 μg subcutaneously daily)
Number of subjects: 29
Study 23099796 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide (20 μg subcutaneously daily)
Number of subjects: 29
Study 23099796 — intervention group
Group type: COMPARATOR
Intervention: Risedronate (35 mg weekly)
Number of subjects: 29
Study 23099796 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with risedronate and teriparatide
Number of subjects: 29
Study 23099796 — intervention group
Group type: COMPARATOR
Intervention: All therapies (combination, teriparatide, risedronate)
Number of subjects: 29
Study 19837395 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic TAPP herniorraphy
Number of subjects: 1795
Study 18398097 — intervention group
Group type: COMPARATOR
Intervention: TAC (docetaxel at 75 mg/m², doxorubicin at 50 mg/m², cyclophosphamide at 500 mg/m²)
Number of subjects: 622
Study 18398097 — intervention group
Group type: EXPERIMENTAL
Intervention: NX (vinorelbine at 25 mg/m² and capecitabine at 2000 mg/m²)
Number of subjects: 622
Study 18398097 — intervention group
Group type: COMPARATOR
Intervention: TAC
Number of subjects: 622
Study 18398097 — intervention group
Group type: EXPERIMENTAL
Intervention: NX
Number of subjects: 622
Study 16518835 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete-choice contingent valuation (CV) survey
Number of subjects: 0
Study 16518835 — intervention group
Group type: EXPERIMENTAL
Intervention: Parametric estimation of mean and median WTP
Number of subjects: 0
Study 14607156 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately imageable words mixed with high image nouns
Number of subjects: 0
Study 14607156 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately imageable words mixed with low image nouns
Number of subjects: 0
Study 10879332 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 10% invert sugar
Number of subjects: 32
Study 10879332 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution with 5% dextrose (D5LR)
Number of subjects: 32
Study 8880694 — intervention group
Group type: EXPERIMENTAL
Intervention: Propentofylline (HWA 285)
Number of subjects: 30
Study 8880694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8401245 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral strategies group (n = 42)
Number of subjects: 156
Study 8401245 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral strategies with instruction group (n = 41)
Number of subjects: 156
Study 8401245 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance group (n = 32)
Number of subjects: 156
Study 8401245 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (n = 41)
Number of subjects: 156
Study 3517537 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide impregnated adhesive plaster (zinc tape)
Number of subjects: 1483
Study 3517537 — intervention group
Group type: COMPARATOR
Intervention: Conventional antiseptic soaked gauze dressings (control)
Number of subjects: 1483
Study 30326932 — intervention group
Group type: EXPERIMENTAL
Intervention: well-being therapy
Number of subjects: 30
Study 30326932 — intervention group
Group type: COMPARATOR
Intervention: control condition
Number of subjects: 30
Study 29328643 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous abortion group (group S)
Number of subjects: 120
Study 29328643 — intervention group
Group type: EXPERIMENTAL
Intervention: Missed abortion group (group M)
Number of subjects: 120
Study 29328643 — intervention group
Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 120
Study 29328643 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous abortion group (group S) and Control group (group N)
Number of subjects: 120
Study 29328643 — intervention group
Group type: COMPARATOR
Intervention: Missed abortion group (group M) and Control group (group N)
Number of subjects: 120
Study 25019381 — intervention group
Group type: EXPERIMENTAL
Intervention: Connecting with a stranger
Number of subjects: 0
Study 25019381 — intervention group
Group type: COMPARATOR
Intervention: Disconnected (not connecting with a stranger)
Number of subjects: 0
Study 25019381 — intervention group
Group type: COMPARATOR
Intervention: Normal commuting (no specific instructions)
Number of subjects: 0
Study 25019381 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking to a participant in a laboratory waiting room
Number of subjects: 0
Study 22508148 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole alone (40 mg per day)
Number of subjects: 178
Study 22508148 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole plus aspirin (40 mg per day + 100 mg per day)
Number of subjects: 178
Study 20570363 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial trabeculectomy in the study eye
Number of subjects: 300
Study 20570363 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated fellow eye)
Number of subjects: 300
Study 18666235 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 121
Study 18666235 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol plus isosorbide‐5‐mononitrate (N+I)
Number of subjects: 121
Study 15805317 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (5 mg orally) with acetaminophen
Number of subjects: 73
Study 15805317 — intervention group
Group type: COMPARATOR
Intervention: Hydrocodone (5 mg orally) with acetaminophen
Number of subjects: 73
Study 12839688 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal interposition esophagojejunostomy (Group D)
Number of subjects: 120
Study 12839688 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-y esophagojejunostomy (Group A)
Number of subjects: 120
Study 12839688 — intervention group
Group type: EXPERIMENTAL
Intervention: P pouch with Roux-en-y esophagojejunostomy (Group B)
Number of subjects: 120
Study 12839688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hunt-Lawrence esophagojejunostomy (Group C)
Number of subjects: 120
Study 12839688 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 healthy persons)
Number of subjects: 120
Study 10601173 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg/day for 48 hours)
Number of subjects: 10
Study 10601173 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study 10601173 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 10
Study 10601173 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood method
Number of subjects: 10
Study 7588349 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (N-butyl-2-cyanoacrylate and ethanolamine oleate)
Number of subjects: 114
Study 7588349 — intervention group
Group type: COMPARATOR
Intervention: Sclerosis group (ethanolamine oleate)
Number of subjects: 114
Study 7588349 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 114
Study 7588349 — intervention group
Group type: COMPARATOR
Intervention: Sclerosis group
Number of subjects: 114
Study 1952471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone (3 g every 12 hours) plus piperacillin (75 mg/kg every 6 hours)
Number of subjects: 429
Study 1952471 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (2 g every 8 hours) plus piperacillin (75 mg/kg every 6 hours)
Number of subjects: 429
Study 1952471 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem alone (1.0 g or 0.5 g every 6 hours)
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Imipenem (4 g/d)
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone plus piperacillin
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus piperacillin
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Imipenem (2 g/d)
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Double beta-lactam therapy
Number of subjects: 429
Study 1952471 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 429
Study 7191790 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g epicillin plus 1 g probenecid
Number of subjects: 260
Study 7191790 — intervention group
Group type: COMPARATOR
Intervention: 2 g epicillin alone
Number of subjects: 260
Study 7191790 — intervention group
Group type: COMPARATOR
Intervention: 1 g epicillin, 1 g cephradine plus 1 g probenecid
Number of subjects: 260
Study 7191790 — intervention group
Group type: COMPARATOR
Intervention: 1 g epicillin and 1 g cephradine
Number of subjects: 260
Study 30772993 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized calf blood extract eye drops (DCBE group)
Number of subjects: 114
Study 30772993 — intervention group
Group type: COMPARATOR
Intervention: Control group (anti-inflammatory drugs only)
Number of subjects: 114
Study 30772993 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose sodium eye drops (CMC group)
Number of subjects: 114
Study 30772993 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human epidermal growth factor eye drops (rEGF group)
Number of subjects: 114
Study 30772993 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 114
Study 25874620 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB
Number of subjects: 3276
Study 23141817 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide (1.8 mg once daily)
Number of subjects: 912
Study 23141817 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (2 mg once weekly)
Number of subjects: 912
Study 22002979 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 500
Study 22002979 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 500
Study 19083426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (125 mg daily)
Number of subjects: 48
Study 19083426 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 48
Study 16412552 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg prednisolone intravenously twice a day
Number of subjects: 31
Study 16412552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 14580743 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression-only telephone CPR
Number of subjects: 59
Study 14580743 — intervention group
Group type: COMPARATOR
Intervention: Standard telephone CPR instructions
Number of subjects: 59
Study 11052521 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin supplementation (24 g daily for three weeks)
Number of subjects: 20
Study 11052521 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin supplementation
Number of subjects: 20
Study 11052521 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin treatment
Number of subjects: 20
Study 11052521 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after wash-out period)
Number of subjects: 20
Study 8774268 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (280 mg/day)
Number of subjects: 100
Study 8774268 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hydrogenated coconut oil)
Number of subjects: 100
Study 1290314 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg daily from the third postoperative day, increasing to 20 mg daily after 1 week for 11 weeks
Number of subjects: 100
Study 1290314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 6727564 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 245C 150 micrograms
Number of subjects: 6
Study 6727564 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 245C 50 micrograms
Number of subjects: 6
Study 6727564 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 245C 50 and 150 micrograms
Number of subjects: 6
Study 6727564 — intervention group
Group type: EXPERIMENTAL
Intervention: BW 245C
Number of subjects: 6
Study 6727564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31712086 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tACS (10 Hz, 1 mA)
Number of subjects: 30
Study 31712086 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tACS (20 Hz, 1 mA)
Number of subjects: 30
Study 31712086 — intervention group
Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 30
Study 30340524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided selective nerve block of the median, ulnar, and medial antebrachial cutaneous nerves at the upper‐median 1/3 of the arm, and a block of the radial and musculocutaneous nerves at the low‐median 1/3 of the arm.
Number of subjects: 24
Study 30340524 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided axillary brachial plexus blocks.
Number of subjects: 24
Study 28431122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral and mindfulness‐based group sleep intervention (n = 63)
Number of subjects: 123
Study 28431122 — intervention group
Group type: COMPARATOR
Intervention: Active control 'study skills' intervention (n = 60)
Number of subjects: 123
Study 26548675 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis education program (six-weekly education sessions)
Number of subjects: 130
Study 26548675 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 130
Study 24270950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive guidance by a healthcare team on a protocol for diabetes care (n=95)
Number of subjects: 182
Study 24270950 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=87)
Number of subjects: 182
Study 22032743 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral anodal dorsolateral prefrontal cortex (DLPFC) stimulation (n = 8)
Number of subjects: 12